Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE)

The College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, the Sierra Leone Ministry of Health and Sanitation (MoHS), and the U.S. Centers for Disease Control and Prevention (CDC) are working together on an Ebola vaccine clinical trial in Sierra Leone.

What is STRIVE?

STRIVE stands for the Sierra Leone Trial to Introduce a Vaccine against Ebola. It is a combined Phase 2 and Phase 3 clinical trial designed to assess the safety and efficacy of the rVSV-ZEBOV candidate Ebola vaccine. STRIVE is expanding on the information on safety and immune response available from previous smaller studies. Learn more about clinical trial phases.

Where is STRIVE taking place?

The study is being conducted in Sierra Leone, one of the countries heavily affected by the 2014-2015 Ebola outbreak. The study is taking place in five districts in Sierra Leone:

• Western Area Rural
• Western Area Urban, which contains Freetown
• Port Loko (3 chiefdoms)
• Bombali (3 chiefdoms)
• Tonkolili (1 chiefdom)

Fuente: https://www.cdc.gov/vhf/ebola/strive/qa.html